Impact on MPN Symptoms and Quality of Life of Front Line Pegylated Interferon Alpha-2a Vs. Hydroxyurea in High Risk Polycythemia Vera and Essential Thrombocythemia: Interim Analysis Results of Myeloproliferative Disorders Research Consortium (MPD-RC) 112 Global Phase III Trial

Ruben A. Mesa; Ronald Hoffman; Heidi E Kosiorek; Josef T. Prchal; Claire N Harrison; Mary Frances McMullin; Abdulraheem Yacoub; Alessandro Rambaldi; Dmitriy Berenzon; Alessandro M Vannucchi; Joanne C. Ewing; Casey L. O'Connell; Jean-Jacques Kiladjian; Adam  Mead; Elliott F. Winton,; David S.  Leibowitz; Valerio De Stefano; Murat o. Arcasoy; Craig m. Kessler

Impact on MPN Symptoms and Quality of Life of Front Line Pegylated Interferon Alpha-2a Vs. Hydroxyurea in High Risk Polycythemia Vera and Essential Thrombocythemia: Interim Analysis Results of Myeloproliferative Disorders Research Consortium (MPD-RC) 112 Global Phase III Trial

Ruben A. Mesa, Ronald Hoffman, Heidi E Kosiorek, Josef T. Prchal, Claire N Harrison, Mary Frances McMullin, Abdulraheem Yacoub, Alessandro Rambaldi, Dmitriy Berenzon, Alessandro M Vannucchi, Joanne C. Ewing, Casey L. O'Connell, Jean-Jacques Kiladjian, Adam Mead, Elliott F. Winton,, David S. Leibowitz, Valerio De Stefano, Murat o. Arcasoy, Craig m. Kessler

Research output: Chapter in Book/Report/Conference proceeding › Conference contribution

Original language	English
Title of host publication	Oral and Poster Abstracts for 58th Annual Meeting and Exposition for ASH
Place of Publication	USA
Publisher	American Society of Hematology
Publication status	Published - 05 Dec 2016
Event	58th Annual Meeting & Exposition - San Diego, United States Duration: 03 Dec 2016 → 06 Dec 2016

Conference

Conference	58th Annual Meeting & Exposition
Country/Territory	United States
City	San Diego
Period	03/12/2016 → 06/12/2016

Cite this

Mesa, R. A., Hoffman, R., E Kosiorek, H., Prchal, J. T., Harrison, C. N., McMullin, M. F., Yacoub, A., Rambaldi, A., Berenzon, D., Vannucchi, A. M., Ewing, J. C., O'Connell, C. L., Kiladjian, J.-J., Mead, A., Winton, E. F., Leibowitz, D. S., De Stefano, V., Arcasoy, M. O., & Kessler, C. M. (2016). Impact on MPN Symptoms and Quality of Life of Front Line Pegylated Interferon Alpha-2a Vs. Hydroxyurea in High Risk Polycythemia Vera and Essential Thrombocythemia: Interim Analysis Results of Myeloproliferative Disorders Research Consortium (MPD-RC) 112 Global Phase III Trial. In Oral and Poster Abstracts for 58th Annual Meeting and Exposition for ASH Article 4271 American Society of Hematology.

Mesa, Ruben A. ; Hoffman, Ronald ; E Kosiorek, Heidi et al. / Impact on MPN Symptoms and Quality of Life of Front Line Pegylated Interferon Alpha-2a Vs. Hydroxyurea in High Risk Polycythemia Vera and Essential Thrombocythemia: Interim Analysis Results of Myeloproliferative Disorders Research Consortium (MPD-RC) 112 Global Phase III Trial. Oral and Poster Abstracts for 58th Annual Meeting and Exposition for ASH. USA : American Society of Hematology, 2016.

@inproceedings{64f33427c49848dabfc6ef2a5f0d6086,

title = "Impact on MPN Symptoms and Quality of Life of Front Line Pegylated Interferon Alpha-2a Vs. Hydroxyurea in High Risk Polycythemia Vera and Essential Thrombocythemia: Interim Analysis Results of Myeloproliferative Disorders Research Consortium (MPD-RC) 112 Global Phase III Trial",

author = "Mesa, {Ruben A.} and Ronald Hoffman and {E Kosiorek}, Heidi and Prchal, {Josef T.} and Harrison, {Claire N} and McMullin, {Mary Frances} and Abdulraheem Yacoub and Alessandro Rambaldi and Dmitriy Berenzon and Vannucchi, {Alessandro M} and Ewing, {Joanne C.} and O'Connell, {Casey L.} and Jean-Jacques Kiladjian and Adam Mead and Winton,, {Elliott F.} and Leibowitz, {David S.} and {De Stefano}, Valerio and Arcasoy, {Murat o.} and Kessler, {Craig m.}",

year = "2016",

month = dec,

day = "5",

language = "English",

booktitle = "Oral and Poster Abstracts for 58th Annual Meeting and Exposition for ASH",

publisher = "American Society of Hematology",

address = "United States",

note = "58th Annual Meeting & Exposition ; Conference date: 03-12-2016 Through 06-12-2016",

}

Mesa, RA, Hoffman, R, E Kosiorek, H, Prchal, JT, Harrison, CN, McMullin, MF, Yacoub, A, Rambaldi, A, Berenzon, D, Vannucchi, AM, Ewing, JC, O'Connell, CL, Kiladjian, J-J, Mead, A, Winton, EF, Leibowitz, DS, De Stefano, V, Arcasoy, MO & Kessler, CM 2016, Impact on MPN Symptoms and Quality of Life of Front Line Pegylated Interferon Alpha-2a Vs. Hydroxyurea in High Risk Polycythemia Vera and Essential Thrombocythemia: Interim Analysis Results of Myeloproliferative Disorders Research Consortium (MPD-RC) 112 Global Phase III Trial. in Oral and Poster Abstracts for 58th Annual Meeting and Exposition for ASH., 4271, American Society of Hematology, USA, 58th Annual Meeting & Exposition, San Diego, United States, 03/12/2016.

Impact on MPN Symptoms and Quality of Life of Front Line Pegylated Interferon Alpha-2a Vs. Hydroxyurea in High Risk Polycythemia Vera and Essential Thrombocythemia: Interim Analysis Results of Myeloproliferative Disorders Research Consortium (MPD-RC) 112 Global Phase III Trial. / Mesa, Ruben A.; Hoffman, Ronald; E Kosiorek, Heidi et al.
Oral and Poster Abstracts for 58th Annual Meeting and Exposition for ASH. USA: American Society of Hematology, 2016. 4271.

Research output: Chapter in Book/Report/Conference proceeding › Conference contribution

TY - GEN

T1 - Impact on MPN Symptoms and Quality of Life of Front Line Pegylated Interferon Alpha-2a Vs. Hydroxyurea in High Risk Polycythemia Vera and Essential Thrombocythemia: Interim Analysis Results of Myeloproliferative Disorders Research Consortium (MPD-RC) 112 Global Phase III Trial

AU - Mesa, Ruben A.

AU - Hoffman, Ronald

AU - E Kosiorek, Heidi

AU - Prchal, Josef T.

AU - Harrison, Claire N

AU - McMullin, Mary Frances

AU - Yacoub, Abdulraheem

AU - Rambaldi, Alessandro

AU - Berenzon, Dmitriy

AU - Vannucchi, Alessandro M

AU - Ewing, Joanne C.

AU - O'Connell, Casey L.

AU - Kiladjian, Jean-Jacques

AU - Mead, Adam

AU - Winton,, Elliott F.

AU - Leibowitz, David S.

AU - De Stefano, Valerio

AU - Arcasoy, Murat o.

AU - Kessler, Craig m.

PY - 2016/12/5

Y1 - 2016/12/5

M3 - Conference contribution

BT - Oral and Poster Abstracts for 58th Annual Meeting and Exposition for ASH

PB - American Society of Hematology

CY - USA

T2 - 58th Annual Meeting & Exposition

Y2 - 3 December 2016 through 6 December 2016

ER -

Mesa RA, Hoffman R, E Kosiorek H, Prchal JT, Harrison CN, McMullin MF et al. Impact on MPN Symptoms and Quality of Life of Front Line Pegylated Interferon Alpha-2a Vs. Hydroxyurea in High Risk Polycythemia Vera and Essential Thrombocythemia: Interim Analysis Results of Myeloproliferative Disorders Research Consortium (MPD-RC) 112 Global Phase III Trial. In Oral and Poster Abstracts for 58th Annual Meeting and Exposition for ASH. USA: American Society of Hematology. 2016. 4271